Skip to main content

Table 4 Acute and late gastro-intestinal (GI) and genito-urinary (GU) toxicities profiles:

From: Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?

 

Pre-treatment

Acute

Late

 

GI

GU

GI

GU

GI

GU

RTOG

G1

3 (2.4 %)

19 (15.2%)

54 (43.2%)

47 (37.6%)

20 (16.0%)

17 (13.6%)

RTOG

G2

None

2 (1.6%)

19 (15.2%)

50 (40.0%)

6 (4.8%)

4 (3.2%)

RTOG

G3

None

None

2 (1.6%)

3 (2.4%)

None

None

RTOG

G4/G5

None

None

None

None

None

None

  1. RTOG: Radiation Therapy Oncology Group